معرفی
Professor Charles Marshall is a Professor of Clinical Neurology at Queen Mary University of London and leads dementia research at the Wolfson Institute of Population Health. He is a Consultant Neurologist at Barts Health NHS Trust and Clinical Director for the NHS London Dementia Clinical Network. His work focuses on early detection of dementia through biomarkers (digital, blood, neuroimaging), health inequalities in neurodegenerative diseases, and epidemiological studies of dementia and Parkinson’s disease.
His research integrates clinical practice with population-level analysis, emphasizing culturally diverse cohorts in East London. He collaborates with the Medical College of Saint Bartholomew’s Hospital Trust and leads initiatives like the London-Dhaka Parkinson’s Cognition Study. His projects include developing AI-driven diagnostic tools (e.g., SLaM Image Bank) and investigating the societal impact of neurodegenerative conditions.
Prof. Marshall supervises four doctoral students exploring topics such as biomarker validity in ethnic minorities, cognitive impairment in Parkinson’s, and dementia risk prediction. He actively engages in public health advocacy, including studies on dementia diagnosis equity and the ethical use of AI in healthcare.
His research has addressed critical issues like the bidirectional relationship between depression and dementia, genetic risk correlations between neurological disorders, and the role of social determinants in disease progression. He is also involved in translational medicine, preparing for future disease-modifying therapies and optimizing NHS dementia service delivery.
